{"id":19770,"date":"2023-11-01T06:48:39","date_gmt":"2023-11-01T11:48:39","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=case_study&#038;p=19770"},"modified":"2023-12-29T10:44:00","modified_gmt":"2023-12-29T15:44:00","slug":"value-drug-company-v-takeda-pharmaceuticals-u-s-a-inc-et-al","status":"publish","type":"case_study","link":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/","title":{"rendered":"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al."},"content":{"rendered":"","protected":false},"featured_media":19733,"template":"","categories":[47,65],"tags":[],"asset_type":[79],"class_list":["post-19770","case_study","type-case_study","status-publish","has-post-thumbnail","hentry","category-antitrust-and-competition","category-life-sciences"],"acf":[],"yoast_head":"\n<title>Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al. | Cornerstone Research<\/title>\n<meta name=\"description\" content=\"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.\" \/>\n<meta property=\"og:description\" content=\"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Cornerstone Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CornerstoneResearchInc\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-29T15:44:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Cornerstone_Res\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/\",\"url\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/\",\"name\":\"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al. | Cornerstone Research\",\"isPartOf\":{\"@id\":\"https:\/\/www.cornerstone.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg\",\"datePublished\":\"2023-11-01T11:48:39+00:00\",\"dateModified\":\"2023-12-29T15:44:00+00:00\",\"description\":\"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage\",\"url\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg\",\"width\":1707,\"height\":2560,\"caption\":\"ampoules running on the conveyor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cornerstone.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cornerstone.com\/#website\",\"url\":\"https:\/\/www.cornerstone.com\/\",\"name\":\"Cornerstone Research\",\"description\":\"Economic and Financial Consulting and Expert Testimony\",\"publisher\":{\"@id\":\"https:\/\/www.cornerstone.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cornerstone.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cornerstone.com\/#organization\",\"name\":\"Cornerstone Research\",\"url\":\"https:\/\/www.cornerstone.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg\",\"contentUrl\":\"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg\",\"width\":1000,\"height\":61,\"caption\":\"Cornerstone Research\"},\"image\":{\"@id\":\"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CornerstoneResearchInc\",\"https:\/\/x.com\/Cornerstone_Res\",\"https:\/\/www.linkedin.com\/company\/cornerstone-research\/\"]}]}<\/script>\n","yoast_head_json":{"title":"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al. | Cornerstone Research","description":"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/","og_locale":"en_US","og_type":"article","og_title":"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.","og_description":"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.","og_url":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/","og_site_name":"Cornerstone Research","article_publisher":"https:\/\/www.facebook.com\/CornerstoneResearchInc","article_modified_time":"2023-12-29T15:44:00+00:00","og_image":[{"width":1707,"height":2560,"url":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Cornerstone_Res","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/","url":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/","name":"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al. | Cornerstone Research","isPartOf":{"@id":"https:\/\/www.cornerstone.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage"},"image":{"@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg","datePublished":"2023-11-01T11:48:39+00:00","dateModified":"2023-12-29T15:44:00+00:00","description":"Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.","breadcrumb":{"@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#primaryimage","url":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg","contentUrl":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2023\/10\/iStock-1422967697-scaled.jpg","width":1707,"height":2560,"caption":"ampoules running on the conveyor"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cornerstone.com\/insights\/cases\/value-drug-company-takeda-pharmaceuticals-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cornerstone.com\/"},{"@type":"ListItem","position":2,"name":"Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al."}]},{"@type":"WebSite","@id":"https:\/\/www.cornerstone.com\/#website","url":"https:\/\/www.cornerstone.com\/","name":"Cornerstone Research","description":"Economic and Financial Consulting and Expert Testimony","publisher":{"@id":"https:\/\/www.cornerstone.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cornerstone.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cornerstone.com\/#organization","name":"Cornerstone Research","url":"https:\/\/www.cornerstone.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg","contentUrl":"https:\/\/www.cornerstone.com\/wp-content\/uploads\/2022\/01\/Cornerstone-Research-Logo.jpg","width":1000,"height":61,"caption":"Cornerstone Research"},"image":{"@id":"https:\/\/www.cornerstone.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CornerstoneResearchInc","https:\/\/x.com\/Cornerstone_Res","https:\/\/www.linkedin.com\/company\/cornerstone-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/19770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":6,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/19770\/revisions"}],"predecessor-version":[{"id":20207,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/case_study\/19770\/revisions\/20207"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/media\/19733"}],"wp:attachment":[{"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/media?parent=19770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/categories?post=19770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/tags?post=19770"},{"taxonomy":"asset_type","embeddable":true,"href":"https:\/\/www.cornerstone.com\/wp-json\/wp\/v2\/asset_type?post=19770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}